elexacaftor: Clinical Trials

2 trials of elexacaftor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow elexacaftor: new trials by email Literature Review of elexacaftor trials Research Report on elexacaftor

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trikafta in Cystic Fibrosis Patients
Trikafta - Cystic Fibrosis
Phase 2CompletedEmory University422019-09-042026-08-11
A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis
IVA, TEZ/IVA, VX-445 - Cystic Fibrosis
Phase 1 / Phase 2CompletedVertex Pharmaceuticals Incorporated2252017-01-232022-01-18

Conditions studied

Cystic Fibrosis (2)

Sponsors

Emory University (1)  ·  Vertex Pharmaceuticals Incorporated (1)

Countries

United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Netherlands (1)

Top investigators

Eric Sorscher, MD (1)

Results publications

PMID 30334692, PMID 33331662, PMID 37983082, PMID 39208836, PMID 42271629

NIH funding

2017 (1), R01HL139876 (1)